HealthMore in Health→
FDA Pushes Real-Time, AI-Assisted Trial Oversight in Bid to Speed Drug Development
Key Takeaways
- Candidate metadata says the FDA is launching an effort to speed up clinical trials using AI.
- The supplied excerpt says real-time monitoring may shorten the interval between trial phases.
- The initiative points to a regulatory shift toward more continuous oversight of clinical data.
DE
DT Editorial Team··via statnews.com
